サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1788306

パルスフィールドアブレーションの世界市場

Pulsed Field Ablation

出版日
ページ情報
英文 174 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
パルスフィールドアブレーションの世界市場
出版日: 2025年08月12日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 174 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

パルスフィールドアブレーションの世界市場は2030年までに60億米ドルに達する見込み

2024年に9億8,590万米ドルと推定されるパルスフィールドアブレーションの世界市場は、分析期間2024-2030年にCAGR 34.9%で成長し、2030年には60億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるカテーテルは、CAGR 37.2％を記録し、分析期間終了時には46億米ドルに達すると予測されます。ジェネレーターセグメントの成長率は、分析期間中CAGR 28.8％と推定されます。

米国市場は2億5,920万米ドル、中国はCAGR 33.0％で成長予測

米国のパルスフィールドアブレーション市場は、2024年には2億5,920万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに8億8,500万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは33.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ32.2%と30.0%と予測されています。欧州では、ドイツがCAGR 24.1%で成長すると予測されています。

世界のパルスフィールドアブレーション市場- 主要動向と促進要因まとめ

パルスフィールドアブレーションは心臓電気生理学をどのように形成しているか？

パルスフィールドアブレーション（PFA）は、心房細動（AF）治療のための従来の熱アブレーション技術に代わる、より安全で高精度な治療法を提供することで、心臓電気生理学の分野に革命をもたらしています。熱や極寒を利用して機能不全の心臓組織を破壊するラジオ波（RF）や冷凍アブレーションとは異なり、PFAは高電圧の電気パルスを用い、周囲の構造物への付随的損傷を最小限に抑えながら、心臓細胞を選択的に標的とします。この非熱的アプローチは、食道損傷、呼吸神経損傷、肺静脈狭窄などの合併症のリスクを大幅に減少させ、PFAを心房細動治療における画期的な技術にしています。心房細動の有病率の増加は、人口の高齢化と心血管疾患率の上昇に後押しされており、革新的で低侵襲な治療ソリューションへの需要が高まっています。PFAの優れた安全性と効率性が臨床試験で実証され続けているため、この技術を採用する電気生理学者が増えており、世界中の心房細動患者の標準治療が変化しつつあります。

どのような技術の進歩がパルスフィールドアブレーションの成長を牽引しているのか？

先進的なカテーテルデザインとエネルギー供給システムの開発が、インターベンショナル・カーディオロジーにおけるパルスフィールドアブレーションの採用を後押ししています。最新のPFAカテーテルは、正確、迅速、均一なエネルギー送達を可能にする多電極アレイを備えており、手技時間を短縮し、治療効果を高めます。リアルタイムのイメージングやマッピング技術との統合により精度がさらに向上し、電気生理学者は標的アブレーションのための詳細な心臓組織モデルを作成できるようになりました。さらに、AIを活用したソフトウェア・ソリューションがPFAシステムに組み込まれ、パルスシーケンスとエネルギー照射を最適化することで、患者に合わせた治療計画が実現されています。可変パルス変調機能を備えたカテーテルベースのPFAシステムの導入は、心房細動以外にもその応用範囲を広げつつあり、心室性不整脈やその他の電気生理学的疾患に対する可能性を探る研究が進行中です。装置メーカーがカテーテルの柔軟性、安全性、エネルギー効率の向上に注力するにつれて、PFAは最新の心臓アブレーション治療の礎石となることが期待されています。

なぜ電気生理学者やヘルスケアプロバイダーはパルスフィールドアブレーションにシフトしているのでしょうか？

パルスフィールドアブレーションは、心房細動の治療をより早く、より安全に、より効果的に行うことができるため、電気生理学者の間で急速に採用が進んでいます。従来のサーマルアブレーション技術では、病変の効果と安全性のバランスをとるためにオペレーターの豊富な経験が必要であったが、PFAの組織選択的メカニズムはアブレーションプロセスを単純化し、手技の複雑さを軽減し、治療成績を向上させる。さらに、PFA手技は回復時間が短く、合併症発生率が低いことが実証されており、患者にとってもヘルスケアプロバイダーにとっても魅力的です。病院や心臓専門センターは、電気生理学的サービスを強化し、患者ケアを改善するための広範なイニシアチブの一環として、PFA技術に投資しています。PFAの長期的な有効性と安全性を裏付ける臨床エビデンスの蓄積は、規制当局の承認や償還政策にも影響を及ぼし、民間と公的医療システムの両方での採用拡大を促しています。ヘルスケアプロバイダーが手技のリスクを最小限に抑え、患者の転帰を最適化しようと努める中、PFAはカテーテルアブレーション手技に望ましいアプローチとして台頭してきています。

パルスフィールドアブレーション市場の主な成長促進要因は？

世界のパルスフィールドアブレーション市場の成長は、心房細動症例の増加、低侵襲心臓治療に対する需要の増加、アブレーションカテーテル技術の継続的な進歩など、いくつかの要因によってもたらされます。心臓アブレーションにおける非熱エネルギー源へのシフトは、PFAを電気生理学における破壊的イノベーションとして位置づけ、医療機器メーカーや研究機関からの投資の増加につながりました。新興市場におけるヘルスケア・インフラの拡大と、医師の意識の高まりやトレーニング・プログラムの充実は、PFAの採用をさらに加速させています。PFAの安全性と有効性を裏付ける臨床データの入手可能性と、主要市場における有利な規制の枠組みが、PFAの商業的実行可能性を高めています。さらに、ヘルスケアプロバイダーと機器メーカーとのコラボレーションが、カテーテル設計、エネルギー供給、手技ワークフローの最適化における技術革新を促進しています。病院や心臓病センターが電気生理学的機能を拡充するにつれて、PFAシステムの需要は増加し、心臓アブレーション治療の主要技術としての役割が確固たるものになると予想されます。

セグメント

コンポーネント（カテーテル、ジェネレーター）;適応症（心房細動、非心房細動）;エンドユース（入院施設、外来施設）

調査対象企業の例

  • Abbott Laboratories
  • AccuPulse Medical
  • Acutus Medical
  • Adagio Medical
  • AngioDynamics
  • Arga Medtech
  • AtriAN Medical
  • AtriCure
  • Biotronik
  • Boston Scientific
  • CardioFocus
  • CathRx
  • Civitas Health
  • ElectroPhysiology Frontiers
  • Elekta
  • EnChannel Medical
  • Galvanize Therapeutics
  • Gradient Medical
  • Hangzhou Dinova EP Technology
  • Hansen Medical

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP32730

Global Pulsed Field Ablation Market to Reach US$6.0 Billion by 2030

The global market for Pulsed Field Ablation estimated at US$985.9 Million in the year 2024, is expected to reach US$6.0 Billion by 2030, growing at a CAGR of 34.9% over the analysis period 2024-2030. Catheters, one of the segments analyzed in the report, is expected to record a 37.2% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth in the Generators segment is estimated at 28.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$259.2 Million While China is Forecast to Grow at 33.0% CAGR

The Pulsed Field Ablation market in the U.S. is estimated at US$259.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$885.0 Million by the year 2030 trailing a CAGR of 33.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 32.2% and 30.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 24.1% CAGR.

Global Pulsed Field Ablation Market - Key Trends & Drivers Summarized

How Is Pulsed Field Ablation Reshaping Cardiac Electrophysiology?

Pulsed Field Ablation (PFA) is revolutionizing the field of cardiac electrophysiology by offering a safer and more precise alternative to traditional thermal ablation techniques for treating atrial fibrillation (AF). Unlike radiofrequency (RF) or cryoablation, which use heat or extreme cold to destroy malfunctioning heart tissue, PFA employs high-voltage electrical pulses to selectively target cardiac cells while minimizing collateral damage to surrounding structures. This non-thermal approach significantly reduces the risk of complications such as esophageal injury, phrenic nerve damage, and pulmonary vein stenosis, making PFA a game-changing technology in AF treatment. The increasing prevalence of atrial fibrillation, fueled by aging populations and rising cardiovascular disease rates, has heightened the demand for innovative and minimally invasive treatment solutions. As clinical trials continue to demonstrate superior safety profiles and efficiency with PFA, more electrophysiologists are embracing this technology, marking a shift in the standard of care for AF patients worldwide.

What Technological Advancements Are Driving the Growth of Pulsed Field Ablation?

The development of advanced catheter designs and energy delivery systems has propelled the adoption of pulsed field ablation in interventional cardiology. Modern PFA catheters feature multi-electrode arrays that allow for precise, rapid, and uniform energy delivery, reducing procedure times and enhancing treatment efficacy. Integration with real-time imaging and mapping technologies has further improved accuracy, enabling electrophysiologists to create detailed cardiac tissue models for targeted ablation. Additionally, AI-driven software solutions are being incorporated into PFA systems to optimize pulse sequences and energy delivery, ensuring personalized treatment plans for patients. The introduction of catheter-based PFA systems with variable pulse modulation capabilities is expanding its applications beyond atrial fibrillation, with ongoing research exploring its potential for ventricular arrhythmias and other electrophysiological disorders. As device manufacturers focus on improving catheter flexibility, safety, and energy efficiency, PFA is expected to become a cornerstone in modern cardiac ablation therapy.

Why Are Electrophysiologists and Healthcare Providers Shifting Toward Pulsed Field Ablation?

The adoption of pulsed field ablation is rapidly increasing among electrophysiologists due to its ability to provide faster, safer, and more effective treatment for atrial fibrillation. Traditional thermal ablation techniques require extensive operator experience to balance lesion effectiveness and safety, whereas PFA’s tissue-selective mechanism simplifies the ablation process, reducing procedural complexity and improving outcomes. Additionally, PFA procedures have demonstrated shorter recovery times and lower complication rates, making them attractive for both patients and healthcare providers. Hospitals and specialized cardiac centers are investing in PFA technology as part of broader initiatives to enhance electrophysiology services and improve patient care. The growing body of clinical evidence supporting PFA’s long-term efficacy and safety is also influencing regulatory approvals and reimbursement policies, encouraging wider adoption in both private and public healthcare systems. As healthcare providers seek to minimize procedural risks and optimize patient outcomes, PFA is emerging as the preferred approach for catheter ablation procedures.

What Are the Key Growth Drivers of the Pulsed Field Ablation Market?

The growth in the global pulsed field ablation market is driven by several factors, including rising atrial fibrillation cases, increasing demand for minimally invasive cardiac procedures, and continuous advancements in ablation catheter technology. The shift toward non-thermal energy sources for cardiac ablation has positioned PFA as a disruptive innovation in electrophysiology, leading to increased investments from medical device manufacturers and research institutions. Expanding healthcare infrastructure in emerging markets, coupled with growing physician awareness and training programs, is further accelerating PFA adoption. The availability of clinical data supporting PFA’s safety and efficacy, along with favorable regulatory frameworks in key markets, is enhancing its commercial viability. Additionally, collaborations between healthcare providers and device manufacturers are driving innovation in catheter design, energy delivery, and procedural workflow optimization. As hospitals and cardiac centers expand their electrophysiology capabilities, the demand for PFA systems is expected to rise, solidifying its role as a leading technology in cardiac ablation therapy.

SCOPE OF STUDY:

The report analyzes the Pulsed Field Ablation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Catheters, Generators); Indication (Atrial Fibrillation, Non-atrial Fibrillation); End-Use (Inpatient Facilities, Outpatient Facilities)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

  • Abbott Laboratories
  • AccuPulse Medical
  • Acutus Medical
  • Adagio Medical
  • AngioDynamics
  • Arga Medtech
  • AtriAN Medical
  • AtriCure
  • Biotronik
  • Boston Scientific
  • CardioFocus
  • CathRx
  • Civitas Health
  • ElectroPhysiology Frontiers
  • Elekta
  • EnChannel Medical
  • Galvanize Therapeutics
  • Gradient Medical
  • Hangzhou Dinova EP Technology
  • Hansen Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Pulsed Field Ablation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Atrial Fibrillation Throws the Spotlight on Pulsed Field Ablation as a Next-Generation Treatment Modality
    • Growing Clinical Preference for Non-Thermal Ablation Technologies Drives Adoption of Pulsed Field Energy Platforms
    • Expansion of Electrophysiology Labs and Cardiac Centers Strengthens Business Case for Advanced Ablation Systems
    • Increased Risk of Collateral Damage with Conventional RF and Cryoablation Spurs Transition to Pulsed Field Approaches
    • Positive Outcomes from Clinical Trials and Real-World Registries Generate Confidence in Efficacy and Safety of Pulsed Field Ablation
    • Technological Advancements in Multielectrode Catheters Propel Development of Single-Shot and Rapid PFA Procedures
    • Regulatory Approvals and CE Markings for First-in-Class Devices Drive Early Commercialization in Europe and Global Markets
    • Surging Investment in Electrophysiology by MedTech Giants Fuels Innovation and Market Entry of Pulsed Field Devices
    • Rising Geriatric Population and Burden of Cardiac Arrhythmias Expands Demand for Safe and Minimally Invasive Ablation Techniques
    • Focus on Procedure Efficiency and Reduced Anesthesia Time Strengthens Market for Outpatient-Based PFA Systems
    • Integration of AI and Real-Time Imaging with PFA Platforms Enhances Precision and Reduces Operator Variability
    • Emergence of Reversible Electroporation Mechanisms Enhances Tissue Selectivity and Minimizes Esophageal and Phrenic Nerve Injury
    • Growing Use of Pulsed Field Ablation in Paroxysmal and Persistent AF Drives Broader Indication Expansion
    • Collaborations Between Hospitals and Device Companies Accelerate Adoption Through Investigator-Led Clinical Programs
    • Increased Focus on Pulmonary Vein Isolation with Minimal Thermal Footprint Supports Next-Gen AF Treatment Paradigms
    • Development of Compact, Fully Integrated PFA Systems Enhances Usability and Expands Adoption in Community Hospitals
    • Favorable Reimbursement Trends for AF Ablation Procedures Drive Economic Justification for Technology Migration to PFA
    • Rising Awareness Among Electrophysiologists About Safety Advantages Over Thermal Techniques Spurs Training and Usage
    • Globalization of Clinical Studies and Regulatory Harmonization Strengthens Pipeline Activity and Market Access for PFA Devices
    • Entry of New Market Players and Startups Encourages Competitive Innovation in Energy Delivery and Catheter Design
    • Surge in Demand for Personalized Cardiac Care and Targeted Ablation Therapy Sustains Long-Term Growth for Pulsed Field Ablation
    • Barriers in Cross-Modality Comparisons and Long-Term Follow-Up Create Opportunities for Robust Evidence Generation and Clinical Differentiation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pulsed Field Ablation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pulsed Field Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Pulsed Field Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Generators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Generators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Atrial Fibrillation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Atrial Fibrillation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Non-atrial Fibrillation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Non-atrial Fibrillation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Inpatient Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Inpatient Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Outpatient Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Outpatient Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 16: USA Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 17: USA 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 18: USA Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • JAPAN
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • CHINA
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: China 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • EUROPE
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Pulsed Field Ablation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Pulsed Field Ablation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • FRANCE
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 48: France Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: France 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 50: France Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • GERMANY
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 54: Germany Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Germany 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • ITALY
    • TABLE 60: Italy Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Italy 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • UNITED KINGDOM
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 66: UK Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: UK 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 68: UK Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 72: Rest of Europe Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Rest of Europe 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 78: Asia-Pacific Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Asia-Pacific 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 84: Rest of World Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of World 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030

IV. COMPETITION